Device brand name · Laryngoscope rigid
GlideScope Core Smart Cable: medical device reports filed with FDA
213 reports name it, 2020–2026. Manufacturer given most often on reports: Verathon Medical Ulc. Product code CCW.
- 213
- device reports naming the brand
- 0% of all MAUDE reports · about 34 a year
- 16
- reports, 12 months to August 2026
- 28 in the 12 months before
- 99.5%
- classified as malfunction
- 94.8% across the product code
- 0.5%
- classified as death, as reported
- 1 reports · not verified by FDA
213 medical device reports received by FDA name the brand "GlideScope Core Smart Cable" (laryngoscope rigid); the manufacturer given most often on reports is Verathon Medical Ulc; received from April 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
16 reports arrived in the 12 months to August 2026, down 43% from 28 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.5%) and death (0.5%); across all laryngoscope, rigid reports (product code CCW) death is recorded in 0.9% and malfunction in 94.8%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are erratic or intermittent display (70%), display or visual feedback problem (57.3%) and no display/image (27.2%). The patient problems coded most often are cardiac arrest and low oxygen saturation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 7,485 reports carrying product code CCW. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Erratic or intermittent display | 149 | 70% | 17.2% |
| Display or visual feedback problem | 122 | 57.3% | 10.6% |
| No display/image | 58 | 27.2% | 31.4% |
| Poor quality image | 30 | 14.1% | 5.8% |
| Loose or intermittent connection | 10 | 4.7% | 1.3% |
| Material deformation | 3 | 1.4% | 0.1% |
| Image display error/artifact | 2 | 0.9% | 1.1% |
| Output problem | 2 | 0.9% | 1.2% |
| Connection problema connection problem | 1 | 0.5% | 1.1% |
| Corrodedthe device corroded | 1 | 0.5% | 0% |
| Deformation due to compressive stress | 1 | 0.5% | 0% |
| Display difficult to read | 1 | 0.5% | 0.1% |
| Fitting problem | 1 | 0.5% | 0.7% |
| Image orientation incorrect | 1 | 0.5% | 0% |
| Intermittent loss of power | 1 | 0.5% | 0.4% |
| Optical obstruction | 1 | 0.5% | 0.2% |
| Optical problem | 1 | 0.5% | 11.7% |
| Unintended movement | 1 | 0.5% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Cardiac arrestthe heart stopped | 1 | 0.5% |
| Low oxygen saturation | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | GlideScope Core Smart Cable | Product code CCW | All MAUDE reports |
|---|---|---|---|
| Reports | 213 | 7,485 | 26,136,888 |
| Share of that pool | — | 2.8% | 0% |
| Classified as death, per 1,000 reports | 5 | 9 | 9 |
| Classified as injury | 0% | 3.8% | 36.2% |
| Classified as malfunction | 99.5% | 94.8% | 62.3% |
| Filed by the manufacturer | 100% | 92.5% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code CCW
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| McGRATH MAC | 724 | 155 | 0.4% |
| Glidescope Avl Video Baton 3-4 | 472 | 0 | 0% |
| McGRATH | 342 | 89 | 1.8% |
| C-MAC Video Laryngoscope D-BLADE | 330 | 177 | 0% |
| GlideScope Spectrum Smart Cable | 286 | 10 | 0% |
| C-MAC Video Laryngoscope MAC #4 | 254 | 150 | 0% |
| C-MAC Video Laryngoscope MAC #3 | 181 | 123 | 0% |
| Salter Labs | 168 | 15 | 0.6% |
| Rusch | 285 | 0 | 1.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about GlideScope Core Smart Cable reports
How many FDA reports name GlideScope Core Smart Cable?
213 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 16 in the latest 12 months.
What kinds of events are reported?
malfunction (99.5%) and death (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
erratic or intermittent display (70%), display or visual feedback problem (57.3%), no display/image (27.2%), poor quality image (14.1%) and loose or intermittent connection (4.7%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that GlideScope Core Smart Cable was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.